Publications by authors named "Alison Tedcastle"

Claim this Profile
P
Production of antigenically stable enterovirus A71 virus-like particles in as a vaccine candidate.
Natalie J Kingston, Joseph S Snowden, Agnieszka Martyna, Mona Shegdar, Keith Grehan, Alison Tedcastle

J Gen Virol· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Production of antigenically stable enterovirus A71 virus-like particles in as a vaccine candidate.
Natalie J Kingston, Joseph S Snowden, Agnieszka Martyna, Mona Shegdar, Keith Grehan, Alison Tedcastle

bioRxiv· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sustained detection of type 2 poliovirus in London sewage between February and July, 2022, by enhanced environmental surveillance.
Dimitra Klapsa, Thomas Wilton, Andrew Zealand, Erika Bujaki, Eugene Saxentoff, Alison Tedcastle

Lancet· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Detection of Enterovirus D68 in Wastewater Samples from the UK between July and November 2021.
Alison Tedcastle, Thomas Wilton, Elaine Pegg, Dimitra Klapsa, Erika Bujaki

Viruses· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cross-Antigenicity between EV71 Sub-Genotypes: Implications for Vaccine Efficacy.
Pei Liu, Yadi Yuan, Bopei Cui, Yaqian Huo, Lianlian Bian, Alison Tedcastle

Viruses· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Differences in Antigenic Structure of Inactivated Polio Vaccines Made From Sabin Live-Attenuated and Wild-Type Poliovirus Strains: Impact on Vaccine Potency Assays.
Laura Crawt, Eleanor Atkinson, Alison Tedcastle, Elaine Pegg,

J Infect Dis· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Oncolytic Group B Adenovirus Enadenotucirev Mediates Non-apoptotic Cell Death with Membrane Disruption and Release of Inflammatory Mediators.
Arthur Dyer, Ying Di, Hugo Calderon, Sam Illingworth, Gray Kueberuwa, Alison Tedcastle

Mol Ther Oncolytics· March 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Actin-resistant DNAse I Expression From Oncolytic Adenovirus Enadenotucirev Enhances Its Intratumoral Spread and Reduces Tumor Growth.
Alison Tedcastle, Sam Illingworth, Alice Brown, Leonard W Seymour, Kerry D Fisher

Mol Ther· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improved in vitro human tumor models for cancer gene therapy.
Philip G Jakeman, Thomas E Hills, Alison B Tedcastle, Ying Di, Kerry D Fisher

Hum Gene Ther· May 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tissue-specific attenuation of oncolytic sindbis virus without compromised genetic stability.
Gray Kueberuwa, Ryan Cawood, Alison Tedcastle, Leonard W Seymour

Hum Gene Ther Methods· April 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The characterization of monoclonal antibodies to human metapneumovirus and the detection of multiple forms of the virus nucleoprotein and phosphoprotein.
Alison B Tedcastle, Fiona Fenwick, Ruth E Ingram, Barney J King, Mark J Robinson

J Med Virol· July 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Virotherapy--cancer targeted pharmacology.
Alison Tedcastle, Ryan Cawood, Ying Di, Kerry D Fisher, Len W Seymour

Drug Discov Today· March 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis